Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Polymorphisms in advanced glycosylation end product-specific receptor (AGER) gene, insulin resistance, and type 2 diabetes mellitus.

Clinica chimica acta; international journal of clinical chemistry - 1 Dec 2008

Goulart A C, Germer S, Rexrode K M, Martin M, Zee R Y L

Abstract excerpt

BACKGROUND: Variants in the advanced glycosylation end product-specific receptor (AGER) gene have been associated with diabetic vasculopathy, however their role in the pathogenesis of insulin resistance and type 2 diabetes mellitus (T2DM) are uncertain. We investigated the relationship of 3 polymorphisms (rs1800625, rs1800624 and rs2070600) in the AGER gene and their haplotypes with T2DM as well as insulin...

Read the complete abstract on PubMed

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Black or African American
Share to Black People
Share to Boston
Share to Glucose Tolerance Test
Share to Insulin Resistance
Share to Receptor for Advanced Glycation End Products
Share to Receptors, Immunologic
Share to Regression Analysis

Source

Identifiers

PMID: 18796298
DOI: 10.1016/j.cca.2008.08.020

Genes

AGER

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Polymorphisms in advanced glycosylation end product-specific receptor (AGER) gene, insulin resistance, and type 2 diabetes mellitus.PMID 18796298Read ↗

Polymorphisms in the advanced glycosylation end product-specific receptor gene and risk of incident myocardial infarction or ischemic stroke.Semantic proximity Read ↗

Susceptibility of six polymorphisms in the receptor for advanced glycation end products to type 2 diabetes: a systematic review and meta-analysis.Semantic proximity Read ↗

Cross-sectional Analysis of AGE-CML, sRAGE, and esRAGE with Diabetes and Cardiometabolic Risk Factors in a Community-Based Cohort.Semantic proximity Read ↗

Polymorphism Screening of Four Genes Encoding Advanced Glycation End-Product Putative ReceptorsSemantic proximity Read ↗

Receptor for advanced glycation end product polymorphisms and type 2 diabetes: the CODAM study.Semantic proximity Read ↗

The ACAA-insertion/deletion polymorphism at the 3' UTR of the IGF-II receptor gene is associated with type 2 diabetes and surrogate markers of insulin resistance.Semantic proximity Read ↗

Circulating concentrations of soluble receptor for AGE are associated with age and AGER gene polymorphisms in children with newly diagnosed type 1 diabetes.Semantic proximity Read ↗

Insulin receptor substrate 1 (IRS1) variants confer risk of diabetes in the Boston Puerto Rican Health Study.Semantic proximity Read ↗

Identification of polymorphisms in the receptor for advanced glycation end products (RAGE) gene: prevalence in type 2 diabetes and ethnic groups.Semantic proximity Read ↗

Soluble receptor and gene polymorphism for AGE: relationship with obesity and cardiovascular risks.Semantic proximity Read ↗

Sequence variation in IGF1R is associated with differences in insulin levels in nondiabetic Old Order Amish.Semantic proximity Read ↗

Functional analysis of the common haplotype in the receptor for advanced glycation end-products gene previously identified as a susceptibility factor for diabetic nephropathy.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.